Morningside Venture Investments Ltd - 02 Feb 2022 Form 4/A - Amendment Insider Report for GreenLight Biosciences Holdings, PBC

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, for Morningside Venture Investments Limited
Issuer symbol
N/A
Transactions as of
02 Feb 2022
Net transactions value
-$10,000,000
Form type
4/A - Amendment
Filing time
17 Mar 2022, 17:11:19 UTC
Date Of Original Report
04 Feb 2022
Previous filing
17 Mar 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRNA Common Stock Conversion of derivative security +12,857,931 12,857,931 02 Feb 2022 Direct F1, F2
transaction GRNA Common Stock Purchase +1,000,000 +7.8% 13,857,931 02 Feb 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Class A Common Stock Conversion of derivative security $0 -12,857,931 -100% $0.000000* 0 02 Feb 2022 Common Stock 12,857,931 Direct F1, F2, F4
transaction GRNA Class A Common Stock Conversion of derivative security $10,000,000 -1,000,000 -100% $10.00* 0 02 Feb 2022 Common Stock 1,000,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date.
F2 Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC.
F3 Represent shares held by MVIL LLC.
F4 Represent shares of Class A Common Stock received in exchange for shares of GreenLight BioSciences, Inc. ("Greenlight") in connection with the business combination transaction of the Issuer. This amendment corrects the number of shares of Class A Common Stock received by Morningside upon conversion of Greenlight shares into Class A Common Stock of the Issuer. The previous number of 12,858,188 has been revised to 12,857,936.

Remarks:

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934.